Detalhe da pesquisa
1.
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia.
Blood Adv
; 8(9): 2182-2192, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38386999
2.
Antibody Response to SARS-CoV-2 Vaccination in Patients With Lymphoproliferative Disorders and Plasma Cell Dyscrasias: Anti-Lymphoma Therapy as a Predictive Biomarker of Response to Vaccination.
Front Oncol
; 12: 840451, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35875166
3.
Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial.
J Clin Oncol
; 39(8): 920-930, 2021 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33417474